Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

EXCLUSIVE: Florida On Cusp Of Adult-Use Legalization Cannabis Sales Boom, CEO Tells Benzinga Conference — 'It's Going To Be Huge'

Published 16/04/2024, 16:51
Updated 16/04/2024, 18:10
© Reuters.  EXCLUSIVE: Florida On Cusp Of Adult-Use Legalization Cannabis Sales Boom, CEO Tells Benzinga Conference — 'It's Going To Be Huge'

Benzinga - by Adam Eckert, Benzinga Staff Writer.

Floridians are set to vote on a recreational marijuana constitutional amendment in November. Several key cannabis players are preparing accordingly.

What To Know: A panel of cannabis executives convened Tuesday at the Benzinga Cannabis Capital Conference in Hollywood, Florida to discuss the economic pulse of the cannabis market.

“Florida has today a million medical card holders, 23 million people living in the state, 130 million, I think, visitors a year — it’s going to be huge,” says AYR Wellness CEO David Goubert said, referring to the vote.

At the beginning of April, the Florida Supreme Court proposed Amendment 3, which would legalize adult non-medical personal use of marijuana products and accessories. If approved, the proposal would take effect in May 2025.

Recreational adult use approval in Florida would be a major step forward for the industry given that Florida is the largest medical market, Goubert says. When approval occurs, sales usually go up between two and three times, he added.

Aaron Miles, CIO of Verano Holdings, is also very optimistic about the proposal in Florida.

Verano’s strategy involves establishing a presence in states with limited licenses, taking market share and positioning itself ahead of adult-use legalization, he said. In Florida, the company already has 74 dispensaries and nearly 3,000 square feet of cultivation.

Miles echoed a lot of what Goubert said about the sales boost that comes with recreational cannabis legalization and suggested that the proposal in Florida could have huge impacts on the company and the industry as a whole. Florida has rules in place that make operations more profitable for cannabis companies as well, he added.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“What we’re doing is making sure that we are going to be able to maximize every ounce of demand that would come out of the state,” Miles said.

Check This Out: 7 Reasons To Tune Into The Benzinga Cannabis Capital Conference, In Person Or Virtually

Jesse Channon, president of The Cannabist Company, said the entire cannabis industry is excited about potential regulatory changes in Florida this year. He suggested that the conversion to recreational use in Florida is inevitable and noted that his company is already preparing for additional states.

Other states with regulatory changes on the horizon include Virginia, Ohio, Pennsylvania, Delaware and West Virginia, he said.

“We deployed an enormous amount of Capex early on in building scaled facilities in pretty much all of the markets that I just mentioned, so as those markets mature and as they ultimately come to conversion for adult use, we’re really well positioned moreso than we have been in other markets prior,” Channon said.

AdvisorShares CIO Dan Ahrens provided an investment perspective on the regulatory situation. Ahrens is the portfolio manager for the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) and the AdvisorShares Pure Cannabis ETF (NYSE:YOLO).

In general, he tries to manage the funds “gently” without a ton of movement, but when there is extra money in the fund, Ahrens looks to position in places with regulatory momentum, like the potential adult use legalization in Florida, he said.

“All of the MSOs are very state-focused because we all know even if we get federal reform that we’re all expecting, there’s still going to be a state focus for adult use,” Ahrens said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want to watch our Cannabis Capital Conference live? For existing subscribers, you can get direct access through our research platform. For new users, you can get instant access here!

Image: Pixabay

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.